SCHEMBL6170033

SCHEMBL6170033

CCCc1nc2ccccc2n1Cc1ccccc1Cl

nearest known ligand 0.68

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.68
KMT2A Q03164 2/20 0.68
SMN1; SMN2 Q16637 2/20 0.68
GAA P10253 1/20 0.68
MAPT P10636 3/20 0.65
TP53 P04637 2/20 0.65
TNF P01375 3/20 0.62
NOD2 Q9HC29 2/20 0.62
NOD1 Q9Y239 2/20 0.62
ALOX5AP P20292 2/20 0.61
TSHR P16473 2/20 0.61
AGTR1 P30556 1/20 0.58
AGTR2 P50052 1/20 0.58
LMNA P02545 1/20 0.58
TDP1 Q9NUW8 1/20 0.56
KDM4E B2RXH2 1/20 0.56
HTT P42858 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8367115 0.89 MEN1 (0.70) MEN1KMT2ASMN1; SMN2MAPTTP53
Hydrochloric Acid SCHEMBL30281719 0.85 TNF (0.64) MEN1KMT2ASMN1; SMN2GAAMAPT
Hydrochloric Acid SCHEMBL29205489 0.85 TNF (0.64) MEN1KMT2ASMN1; SMN2GAAMAPT
SCHEMBL6170831 0.85 SMN1; SMN2 (0.54) MEN1KMT2ASMN1; SMN2GAAMAPT
SCHEMBL6170532 0.83 AGTR1 (0.55) MEN1KMT2ASMN1; SMN2GAAMAPT
SCHEMBL6170454 0.82 ALOX5AP (0.55) MEN1KMT2ASMN1; SMN2GAAMAPT
SCHEMBL7671121 0.81 AGTR1 (0.54) MEN1KMT2ASMN1; SMN2GAAMAPT
SCHEMBL6169342 0.81 AGTR1 (0.62) TP53ALOX5APAGTR1AGTR2TDP1
SCHEMBL6170375 0.81 AGTR1 (0.62) TP53AGTR1AGTR2TDP1
SCHEMBL18535200 0.80 GALR3 (0.72) SMN1; SMN2MAPTTP53TNFNOD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0882718-B1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO (JP) 2005-08-31 EP disclosed
US-6369092-B1 Method for treating neoplasia by exposure to substituted benzimidazole derivatives CELL PATHWAYS, INC. 2002-04-09 US disclosed
US-6352985-B1 CARDIOVASCULAR DISORDERS OR GASTROINTESTINAL DISORDERS, DIABETES (TYPE II DIABETES), DIABETIC COMPLICATIONS METHOD FOR LOWERING THE BLOOD SUGAR LEVEL OF A PATIENT, FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-03-05 US disclosed
US-6166219-A Benzimidazole derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-12-26 US disclosed
EP-0882718-A1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-12-09 EP disclosed